At the ENVI Committee’s vote on the Clinical Trials Regulation on 29 May 2013, Members of the European Parliament (MEPs) took a clear stance in support of enhanced data transparency.
The European Medicines Agency (EMA) draft policy on “publication and access to clinical-trial data” could pave the way to a new era in the disclosure of clinical data on medicines.
14 June 2013 - Comments from The Nordic Cochrane Centre and the International Society of Drug Bulletins
The Clinical Trial Regulation is currently being discussed. As patients, researchers, doctors, scientists and civil society representatives we would like to draw your attention not only to the dangers it encompasses but also to the opportunities it brings along.